Marilia Meira Dias
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marilia Meira Dias has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Eduardo Rochette Ropelle
Laboratory of Molecular Biology of Exercise (LaBMEx), School of Applied Sciences University of Campinas Limeira São Paulo Brazil
2 shared publications - José Barreto Campello Carvalheira
Department of Radiology and Oncology, School of Medical Sciences, University of Campinas, Campinas, SP, Brazil
2 shared publications - Mario Jose Abdalla Saad
Department of Internal Medicine, State University of Campinas (UNICAMP), Campinas 13083-887, SP, Brazil
2 shared publications Alexandre Cassago
Brazilian Nanotechnology National Laboratory, Brazilian Center for Research in Energy and Materials, Campinas, Brazil
1 shared publication- Alliny Cristiny da Silva Bastos
16Division of Oncology, Section of Medical Oncology, Washington University School of Medicine (WashU Medicine), St. Louis, Missouri
1 shared publication - Andre Luis Berteli Ambrosio
São Carlos Institute of Physics, University of São Paulo, São Carlos, Brazil
1 shared publication
Latest Publications
- 19 October 2023
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 30 (12) , 1902-1912
Molecular mechanism of glutaminase activation through filamentation and the role of filaments in mitophagy protection
Glutaminase (GLS), which deaminates glutamine to form glutamate, is a mitochondrial tetrameric protein complex. Although inorganic phosphate (Pi) is known to promote GLS filamentation and activation, the molecular basis of this mechanism is unknown. Here we aimed to determine the molecular mechanism of Pi-induced mouse GLS filamentation and its impact on mitochondrial physiology. Single-particle cryogenic electron microscopy revealed an allosteric mechanism in which Pi binding at the tetramer interface and the activation loop is coupled to direct nucleophile activation at the active site. The active conformation is prone to enzyme filamentation. Notably, human GLS filaments form inside tubulated mitochondria following glutamine withdrawal, as shown by in situ cryo-electron tomography of cells thinned by cryo-focused ion beam milling. Mitochondria with GLS filaments exhibit increased protection from mitophagy. We reveal roles of filamentous GLS in mitochondrial morphology and recycling.
- 19 October 2023
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 30 (12) , 1902-1912
Molecular mechanism of glutaminase activation through filamentation and the role of filaments in mitophagy protection
Glutaminase (GLS), which deaminates glutamine to form glutamate, is a mitochondrial tetrameric protein complex. Although inorganic phosphate (Pi) is known to promote GLS filamentation and activation, the molecular basis of this mechanism is unknown. Here we aimed to determine the molecular mechanism of Pi-induced mouse GLS filamentation and its impact on mitochondrial physiology. Single-particle cryogenic electron microscopy revealed an allosteric mechanism in which Pi binding at the tetramer interface and the activation loop is coupled to direct nucleophile activation at the active site. The active conformation is prone to enzyme filamentation. Notably, human GLS filaments form inside tubulated mitochondria following glutamine withdrawal, as shown by in situ cryo-electron tomography of cells thinned by cryo-focused ion beam milling. Mitochondria with GLS filaments exhibit increased protection from mitophagy. We reveal roles of filamentous GLS in mitochondrial morphology and recycling.
- RetractionOpen Access
- 10 February 2017
- Published by American Diabetes Association in Diabetes
- Vol. 66 (3) , 786-787
Statement of Retraction. A Central Role for Neuronal AMP-Activated Protein Kinase (AMPK) and Mammalian Target of Rapamycin (mTOR) in High-Protein Diet–Induced Weight Loss. Diabetes 2008;57:594–605. DOI: 10.2337/db07-0573
- 10 February 2017
- Published by American Diabetes Association in Diabetes
- Vol. 66 (3) , 786-787
RetractionOpen AccessStatement of Retraction. A Central Role for Neuronal AMP-Activated Protein Kinase (AMPK) and Mammalian Target of Rapamycin (mTOR) in High-Protein Diet–Induced Weight Loss. Diabetes 2008;57:594–605. DOI: 10.2337/db07-0573
- Open Access
- 15 June 2011
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 17 (12) , 3993-4005
Metformin Amplifies Chemotherapy-Induced AMPK Activation and Antitumoral Growth
Purpose: Metformin is a widely used antidiabetic drug whose anticancer effects, mediated by the activation of AMP-activated protein kinase (AMPK) and reduction of mTOR signaling, have become noteworthy. Chemotherapy produces genotoxic stress and induces p53 activity, which can cross-talk with AMPK/mTOR pathway. Herein, we investigate whether the combination of metformin and paclitaxel has an effect in cancer cell lines.
- 15 June 2011
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 17 (12) , 3993-4005
Open AccessMetformin Amplifies Chemotherapy-Induced AMPK Activation and Antitumoral Growth
Purpose: Metformin is a widely used antidiabetic drug whose anticancer effects, mediated by the activation of AMP-activated protein kinase (AMPK) and reduction of mTOR signaling, have become noteworthy. Chemotherapy produces genotoxic stress and induces p53 activity, which can cross-talk with AMPK/mTOR pathway. Herein, we investigate whether the combination of metformin and paclitaxel has an effect in cancer cell lines.